Lumenis AcuPulse
CO2 Fractional/Ablative · CO2 10600nm fractional (SuperPulse)
What it's actually cleared for: Long clearance lineage verified — K100415 (AcuPulse 30/40ST/40WG, 2010) through K212703 (AcuPulse CO2 Laser System, October 2021); indication: incision, ablation, vaporization and coagulation of soft tissue including ablative skin resurfacing, across dermatology and multiple surgical specialties.
Last verified: August 6, 2026 · How we verify
New: $90k–$130k|Used: $25k–$50kmarket estimate, no email required
Bottom line
The sensible CO2: roughly half to two-thirds the price of an UltraPulse, no consumables, and it does 90% of what a medspa actually sells — fractional resurfacing, peri-oral lines, mild-to-moderate scars. What you give up versus UltraPulse Alpha is raw pulse energy for deep SCAAR FX-style work on severe scars, which most non-surgical practices never do. Buy AcuPulse if CO2 is a service line; buy UltraPulse only if scar revision is your identity. Factor in that Lumenis' aesthetics arm has been through ownership churn — pin down service terms before signing.
Overview
Lighter-duty CO2 workhorse, also GYN modes
How it works
The science
A 10,600nm CO2 laser — absorbed by tissue water, vaporizing microscopic columns of skin and heating surrounding dermis to trigger collagen remodeling. In fractional mode (AcuScan scanner) it treats a percentage of the surface, trading a week of downtime for meaningful improvement in wrinkles, sun damage, texture and acne scars; full-ablation mode resurfaces or removes lesions outright. SuperPulse delivery keeps pulses short so tissue vaporizes with less bystander heat than continuous-wave CO2, meaning cleaner healing.
Patented tech
SuperPulse waveform and AcuScan120 scanner — real engineering, but "short-pulse CO2 with a pattern scanner" describes most modern competitors; Lumenis' edge is four decades of CO2 pedigree rather than a patent moat.
Origin
Yokneam, Israel (Lumenis Ltd.).
FDA & regulatory status
What it's actually cleared for:
Long clearance lineage verified — K100415 (AcuPulse 30/40ST/40WG, 2010) through K212703 (AcuPulse CO2 Laser System, October 2021); indication: incision, ablation, vaporization and coagulation of soft tissue including ablative skin resurfacing, across dermatology and multiple surgical specialties.
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
What practices charge
Fractional CO2 full-face ~$1,500-3,000, lighter "lunchtime CO2" passes ~$600-1,200, typically one corrective treatment with optional touch-up. Peri-oral/peri-orbital spot treatments ~$500-900 are easy add-ons to surgical practices.
Consumables & recurring cost
None for standard aesthetic use (disposable tips exist for GYN applications). Budget eventual optics/arm service rather than per-case cost.
Ideal for
Best-fit practice
Physician practices (derm, plastics, facial plastics) adding a resurfacing line, and mature medspas with 45+ patients willing to accept a week of downtime for real correction. Not for downtime-averse clienteles — that's MOXI/Clear + Brilliant territory.
Compliance
Medical director & delegation
Class II prescription surgical laser; ablative CO2 is physician or NP/PA-level in most states with limited delegation latitude — several states restrict ablative resurfacing entirely to licensed medical practitioners.
Contraindications & screening
Recent isotretinoin, active infection, keloid tendency, pregnancy; Fitzpatrick IV+ requires conservative settings and priming due to real PIH risk with any CO2.
Ownership
Warranty & service
1-year standard; extended ~$10K-18K/year, and Lumenis service pricing has a reputation for being firm. Confirm post-acquisition support commitments in writing.
Resale & used market
CO2 workhorses always move — used AcuPulse at ~$25K-60K depending on generation with steady liquidity, though they depreciate faster than Sciton gear.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.